Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
algs · stock forecast · 5 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$20.00
Consensus
$20.00
+303.2% upside
Low
$20.00
Median: $20 · Last Close: $4.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.71 | ↓ 5.00% |
1-day model range: $4.61–$4.81. Peak: $4.81 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ALGS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-01-17 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-01-06 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2023-01-06 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
Wall Street analysts have recently issued updated ratings on Aligos Therapeutics, Inc. (ALGS) stock. Of the recent 23 rating actions, 2 were upgrades and 3 were downgrades. 5 analysts currently cover ALGS.
Analyst Recommendation Trends
ALGS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$20M
↓ 59.8% YoY
Revenue Next Year
$4M
↓ 78.5% YoY
EPS This Year
$-7.05
EPS Next Year
$-4.49
↓ 36.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALGS EPS of $-7.05 for the current fiscal year, based on estimates from 5 analysts. The ALGS revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ALGS stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALGS price target is $20.00 (+303.2% upside), with an analyst consensus of Buy.
The ALGS short-term stock prediction for tomorrow is $4.71 (-5.00%). The ALGS stock prediction for 2030 projects a range of $1–$2.
Aligos Therapeutics, Inc. trades on NASDAQ under the ticker ALGS. The ALGS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
ALGS forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month ALGS price target is $20.00, with a high forecast of $20.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +303.2% potential upside from the current price of $4.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.